MedMen Preliminary Third Quarter 2019 Systemwide Revenue Results

MedMen Enterprises Inc. (MMEN.CN) (MMNFF) (FSE:A2JM6N) is planning on announcing its financial results for the third quarter fiscal 2019, which ended on March 30, 2019, on May 29 2019 after market close. Below is a look at their reasonably positive preliminary third quarter 2019 systemwide revenue results. LOS ANGELES–(BUSINESS WIRE)– Enterprises Inc. (“MedMen” or the […]

hTop StockWatch MedMen

MedMen Inc. Due for a Turnaround?

MedMen Enterprises Inc. (CSE:MMEN) (OTCQX: MMNFF) stock seems to have entered into a reasonably predictable pattern resembling a wave function. This has been going on since late November 2018. This behaviour is very unlike MedMen’s previous 6 months, from June through December 2018, with building highs and appropriate lows. The current value is similar to […]

Jesse_Williams-byROBERT MAXWELL

MedMen (CSE: MMEN) (OTCQX: MMNFF) Has a New Commercial

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX:MMNFF) made history yesterday with it’s new commercial that chronicles the U.S’s history with cannabis featuring Jesse Williamsctor best known for his role in popular television series Grey’s Anatomy. Supported by on of the largest integrated marketing campaigns that company has had to date, the commercial […]


MedMen Warrants (MMEN.wt) Worth the Price ?

Lets start right off with our opinion here at Htop Stockwatch we think the MedMen Warrants (MMEN.wt) are currently worth the price of around $0.72. There are 7,840,909 outstanding. With a strike price of $6.87CAD and an expiry of Sept 27th 2021 with no acceleration clause. CSE listing bulletin. The current share price of MedMen […]

High Top Stock Watch

Time to Buy BlackBerry (TSX:BB) Stock?

After many attempts to rekindle their stock price Blackberry (TSE:BB is onto yet another endeavour of increasing its share in the driver less car market. The one-time smartphone leader has just receiving $40 Million in federal funding to help them as they develop tech to make cars more connected, safer, and ultimately capable of […]

hTop StockWatch MedMen


MEDMEN ENTERPRISES INC’s shares (MMEN.CN OTCMKTS:MMNFF) have been registering a slight increase (~1.76%) in short interest. MMEN’s total short interest was ~973,500 shares in February as published by FINRA. Its up 1.8% from the previously reported ~956,500 shares. With around 3.8M average volume, it will take short sellers not even a full day to cover […]

MedMen(MMEN.CN) To Release Q2 Fiscal 2019 Financial Results In Feb

MedMen Enterprises Inc. (MMEN.CN) (MMNFF) (FSE:A2JM6N) is planning on announcing its financial results for the second quarter fiscal 2019, which ended on December 29, 2018, on Feb 27 2019 after market close. LOS ANGELES–(BUSINESS WIRE)– February 1, 2019 MedMen Enterprises Inc. (“MedMen” or the “Company”) (MMEN.CN) (MMNFF) (FSE:A2JM6N) plans to release its financial results for […]

Htop StockWatch Prometic Neg

ProMetic TSE:PLI Releases Q1 2018 Results

The downtrend looks to continue for ProMetic Life Sciences inc.(TSE:PLI)( they have reported their first quarter results for 2018 and it doesn’t look good. As of Wednesday evening the Q1 reports revenues of $4.3 Million compared to an estimated $5.6 Million and operating expenses of ~$30 Million (R&D $22.4MM, SG&A $7.6MM) above the ~$25.5 Million […]

htop StockWatch Lithium Americas TSE:LAC earnings release

Lithium Americas 2018 First Quarter Results (TSX:LAC) (NYSE:LAC)

Lithium Americas (TSX:LAC)(NYSE:LAC) has just reported their 2018 first quarter financial and operating results. Lac’s first quarter ended as of March 31, 2018 with slightly less than expected results. Consisting of a $0.05 loss per share and sales of $1.1 million versus a $1.2 million expectation. Despite this seemingly bad news the consensus towards Lithium […]

High Top Stock Watch

ProMetic Life Sciences(TSE:PLI) Insider Buys $14,800.00

A monumental but likely temporary downtrend is occurring at the moment for ProMetic Life Sciences inc.(TSE:PLI)( I know of one person who would more than likely agree the downtrend is not permanent. As it does not seem to be stopping optimistic insider Martin Leclerc from purchasing $14,800.00 CAD or 20,000 shares of ProMetic Life Sciences […]